Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000443454 | SCV000520393 | likely benign | not specified | 2017-05-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000580863 | SCV000685149 | likely benign | Hereditary cancer-predisposing syndrome | 2017-03-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000580863 | SCV002689814 | uncertain significance | Hereditary cancer-predisposing syndrome | 2017-08-30 | criteria provided, single submitter | clinical testing | The c.-12C>G variant is located in the 5' untranslated region (5’ UTR) of the MSH6 gene. This variant results from a C to G substitution 12 bases upstream from the first translated codon. This nucleotide position is poorly conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Center for Genomic Medicine, |
RCV000443454 | SCV004024776 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003996067 | SCV004832599 | likely benign | Lynch syndrome | 2023-12-01 | criteria provided, single submitter | clinical testing |